Review
Open access
Oct 2026
Combination of antibody–drug conjugates with immunotherapy: a new paradigm in cancer treatment
Immunotherapy, which activates the host immune system to recognize and eliminate tumor cells, has become an important modality in cancer treatments. However, tumor heterogeneity and the immunosuppressive tumor microenvironment often drive resistance to single-agent immunotherapy, thereby limiting its clinical efficacy....
Yong Lai, R. Qin, Zhai-Dong Liu
· Frontiers in Oncology · 0 citations